Rezultati pretrage - Ellin Berman

Detaljiziraj rezultate
  1. 1
    Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells

    Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells od Ellin Berman, Mary L. McBride

    Izdano 1992
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  2. 2
    Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a [see comments]

    Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a [see comments] od Ellin Berman, Glenn Heller, SJ Kempin, Toby Gee, LL Tran, Bayard Clarkson

    Izdano 1990
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    FoxO1-dependent induction of acute myeloid leukemia by osteoblasts in mice

    FoxO1-dependent induction of acute myeloid leukemia by osteoblasts in mice od Aruna Kode, Ioanna Mosialou, Sridharan Manavalan, Chozhavendan Rathinam, Rick A. Friedman, Julie Teruya‐Feldstein, Govind Bhagat, Ellin Berman, Stavroula Kousteni

    Izdano 2015
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    Altered Bone and Mineral Metabolism in Patients Receiving Imatinib Mesylate

    Altered Bone and Mineral Metabolism in Patients Receiving Imatinib Mesylate od Ellin Berman, An S. De Vriese, Robert G. Maki, Martin Fleisher, Suzanne Chanel, Kelly Scheu, Bri-Anne Wilson, Glenn Heller, Nicholas Sauter

    Izdano 2006
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations

    Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gen... od Erdem Göker, Mark Waltham, Albert Kheradpour, Tanya Trippett, Madhu Mazumdar, Y Elisseyeff, Barbara Schnieders, Peter G. Steinherz, C Tan, Ellin Berman

    Izdano 1995
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia

    Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leuk... od Ellin Berman, Glenn Heller, J Santorsa, Susan McKenzie, Toby Gee, Sanford Kempin, Subhash C. Gulati, Michael Andreeff, Jonathan E. Kolitz, Janice Gabrilove

    Izdano 1991
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia

    Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leuk... od Ellin Berman, Glenn Heller, J Santorsa, Susan McKenzie, Toby Gee, SJ Kempin, Subhash C. Gulati, M. Andreeff, Jonathan E. Kolitz, J. Lester Gabrilove

    Izdano 1991
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    NCCN Task Force Report: Tyrosine Kinase Inhibitor Therapy Selection in the Management of Patients With Chronic Myelogenous Leukemia

    NCCN Task Force Report: Tyrosine Kinase Inhibitor Therapy Selection in the Management of Patients With Chronic Myelogenous Leukemia od Susan O’Brien, Ellin Berman, Joseph O. Moore, Javier Pinilla‐Ibarz, Jerald P. Radich, Paul J. Shami, Benjamin D. Smith, David S. Snyder, Hema Sundar, Moshe Talpaz, Meir Wetzler

    Izdano 2011
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia

    Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia od P. Maslak, Tao Dao, Lee M. Krug, Suzanne Chanel, Tatyana Korontsvit, Victoria Zakhaleva, Ronghua Zhang, Jedd D. Wolchok, Jianda Yuan, Javier Pinilla‐Ibarz, Ellin Berman, Mark Weiss, Joseph G. Jurcic, Mark G. Frattini, David A. Scheinberg

    Izdano 2010
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia

    Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia od Bob Löwenberg, Petra Muus, Gert J. Ossenkoppele, Philippe Rousselot, Jean‐Yves Cahn, Norbert Ifrah, Giovanni Martinelli, Sergio Amadori, Ellin Berman, Pieter Sonneveld, Mojca Jongen‐Lavrencic, Sophie Rigaudeau, Paul K. Stockman, Alison Goudie, Stefan Faderl, Elias Jabbour, Hagop M. Kantarjian

    Izdano 2011
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts

    Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts od Aruna Kode, John S. Manavalan, Ioanna Mosialou, Govind Bhagat, Chozha Vendan Rathinam, Na Luo, Hossein Khiabanian, Albert Lee, Vundavalli V. Murty, Richard A. Friedman, Andrea M. Brum, David S. Park, Naomi Galili, Siddhartha Mukherjee, Julie Teruya‐Feldstein, Azra Raza, Raúl Rabadán, Ellin Berman, Stavroula Kousteni

    Izdano 2014
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts

    Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts od Maria Krevvata, Barbara C. Silva, John S. Manavalan, Marta Galán-Díez, Aruna Kode, Brya G. Matthews, David S. Park, Chiyuan A. Zhang, Naomi Galili, Thomas L. Nickolas, David W. Dempster, William C. Dougall, Julie Teruya‐Feldstein, Aris N. Economides, Ivo Kalajzić, Azra Raza, Ellin Berman, Siddhartha Mukherjee, Govind Bhagat, Stavroula Kousteni

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    Chronic Myelogenous Leukemia

    Chronic Myelogenous Leukemia od Susan O’Brien, Ellin Berman, Hossein Borghaei, Daniel J. DeAngelo, Marcel P. Devetten, Steven M. Devine, Harry P. Erba, Jason Gotlib, Madan Jagasia, Joseph O. Moore, Tariq I. Mughal, Javier Pinilla‐Ibarz, Jerald P. Radich, Neil P. Shah, Paul J. Shami, Benjamin D. Smith, David S. Snyder, Martin S. Tallman, Moshe Talpaz, Meir Wetzler

    Izdano 2009
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  14. 14
    Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee

    Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee od James L. Januzzi, Joseph Garasic, Scott E. Kasner, Vickie McDonald, Mark C. Petrie, Jonathan Seltzer, Michael J. Mauro, Kevin Croce, Ellin Berman, Michael W. Deininger, Andreas Hochhaus, Javier Pinilla‐Ibarz, Franck E. Nicolini, Dong‐Wook Kim, Daniel J. DeAngelo, Hagop M. Kantarjian, Jing Xu, Tracey Hall, Shouryadeep Srivastava, Daniel Naranjo, Jorge E. Cortés

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  15. 15
    Chronic Myelogenous Leukemia, Version 1.2015

    Chronic Myelogenous Leukemia, Version 1.2015 od Susan O’Brien, Jerald P. Radich, Camille N. Abboud, Mojtaba Akhtari, Jessica K. Altman, Ellin Berman, Peter Curtin, Daniel J. DeAngelo, Michael W. Deininger, Steven M. Devine, Amir T. Fathi, Jason Gotlib, Madan Jagasia, Patricia Kropf, Joseph O. Moore, Arnel Pallera, Vishnu Reddy, Neil P. Shah, Benjamin D. Smith, David S. Snyder, Meir Wetzler, Kristina M. Gregory, Hema Sundar

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  16. 16
    Chronic Myelogenous Leukemia, Version 1.2014

    Chronic Myelogenous Leukemia, Version 1.2014 od Susan O’Brien, Jerald P. Radich, Camille N. Abboud, Mojtaba Akhtari, Jessica K. Altman, Ellin Berman, Daniel J. DeAngelo, Michael W. Deininger, Steven M. Devine, Amir T. Fathi, Jason Gotlib, Madan Jagasia, Patricia Kropf, Joseph O. Moore, Arnel Pallera, Javier Pinilla‐Ibarz, Vishnu Reddy, Neil P. Shah, Benjamin D. Smith, David S. Snyder, Meir Wetzler, Kristina M. Gregory, Hema Sundar

    Izdano 2013
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    Overcoming adaptive therapy resistance in AML by targeting immune response pathways

    Overcoming adaptive therapy resistance in AML by targeting immune response pathways od Katelyn Melgar, Morgan M. Walker, LaQuita M. Jones, Lyndsey Bolanos, Kathleen Hueneman, Mark Wunderlich, Jian-kang Jiang, Kelli M. Wilson, Xiaohu Zhang, Patrick Sutter, Amy Wang, Xin Xu, Kwangmin Choi, Gregory J. Tawa, Donald L. Lorimer, Jan Abendroth, Eric O’Brien, Scott B. Hoyt, Ellin Berman, Christopher Famulare, James C. Mulloy, Ross L. Levine, John P. Perentesis, Craig J. Thomas, Daniel T. Starczynowski

    Izdano 2019
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017

    NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017 od Arnel Pallera, Jessica K. Altman, Ellin Berman, Camille N. Abboud, Bhavana Bhatnagar, Peter Curtin, Daniel J. DeAngelo, Jason Gotlib, R. Tanner Hagelstrom, Gabriela S. Hobbs, Madan Jagasia, Hagop M. Kantarjian, Patricia Kropf, Leland Metheny, Joseph O. Moore, Evelena P. Ontiveros, Enkhtsetseg Purev, Albert Quiery, Vishnu Reddy, Michal G. Rose, Neil P. Shah, B. Douglas Smith, David S. Snyder, Kendra Sweet, Raoul Tibes, David T. Yang, Kristina M. Gregory, Hema Sundar, Michael W. Deininger, Jerald P. Radich

    Izdano 2016
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  19. 19
    Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

    Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology od Jerald P. Radich, Michael W. Deininger, Camille N. Abboud, Jessica K. Altman, Ellin Berman, Ravi Bhatia, Bhavana Bhatnagar, Peter Curtin, Daniel J. DeAngelo, Jason Gotlib, Gabriela S. Hobbs, Madan Jagasia, Hagop M. Kantarjian, Lori J. Maness, Leland Metheny, Joseph O. Moore, Arnel Pallera, Philip Pancari, Mrinal M. Patnaik, Enkhtsetseg Purev, Michal G. Rose, Neil P. Shah, B. Douglas Smith, David S. Snyder, Kendra Sweet, Moshe Talpaz, James E. Thompson, David T. Yang, Kristina M. Gregory, Hema Sundar

    Izdano 2018
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  20. 20
    Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i>-Mutated AML

    Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i>-Mutated AML od Alexander E. Perl, Giovanni Martinelli, Jorge E. Cortés, Andreas Neubauer, Ellin Berman, Stefania Paolini, Pau Montesinos, Maria R. Baer, Richard A. Larson, Celalettin Üstün, Francesco Fabbiano, Harry P. Erba, Antonio Di Stasi, Robert K. Stuart, Rebecca L. Olin, Margaret Kasner, Fabio Ciceri, Wen‐Chien Chou, Nikolai A. Podoltsev, Christian Récher, Hisayuki Yokoyama, Naoko Hosono, Sung‐Soo Yoon, Je‐Hwan Lee, Timothy S. Pardee, Amir T. Fathi, Chaofeng Liu, Nahla Hasabou, Xuan Liu, Erkut Bahceci, Mark J. Levis

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: